WellMedr Review: What You Are Signing Up For

Weight loss › WellMedr

BalanzGM is reader-supported — we may earn a commission from links on this page, at no extra cost to you. See our affiliate disclosure. This article is information, not medical advice.

3.2OUT OF 5
★★★☆☆

Editorial rating 3.2 / 5 — based on our analysis

Short version. WellMedr does something most of its competitors do not: it sells genuine brand-name Ozempic® and Zepbound® alongside compounded options, so the choice is actually yours. It also publishes precise dose strengths for its ED products, which is rare. Against that, its billing renews every 21 days while the pricing is presented monthly, it publishes no state list, and we could not find a contraindication page for its GLP-1 products anywhere.

Compounded medications are not FDA-approved and are not generic versions of brand-name drugs. Eligibility and treatment are determined by a US-licensed clinician; results vary.

WellMedr at a glance

What it isA US telehealth platform covering weight loss, hormone and sexual health, and hair restoration
How you get itAn assessment the site describes as three minutes, or an AI-assisted chat intake, reviewed by a licensed clinician. Described as an asynchronous workflow
Who reviews itOpenLoop Healthcare Partners, PC and its state affiliates, named in the telehealth consent
TurnaroundSame-day consult slots advertised; orders ship 1–2 business days after approval, delivery typically 3–5 days
Brand-name optionYes — Ozempic® and Zepbound® alongside compounded semaglutide and tirzepatide
Billing cycleEvery 21 days, not monthly — see below
PricingOn the WellMedr site, laid out as four tiers from compounded up to brand-name

The billing detail worth knowing first

The subscription renews every 21 days. WellMedr’s refund and cancellation policy states: “Your subscription will automatically renew every 21 days to ensure continuity of care and medication delivery.”

A 21-day cycle means roughly 17 charges a year, not 12, while the pricing is presented in monthly language. Their terms separately reference “monthly, 3-month, or 6-month cycles depending on your plan”, which does not obviously reconcile with the 21-day clause. Whichever applies to you, work out the annual cost from the renewal interval rather than from the headline figure, and confirm your interval in writing before you start.

Cancellation requires notice at least 72 hours before the billing date. Refunds close early: “Once a purchase is completed and your medical intake has been approved and transmitted to a licensed medical provider and/or pharmacy for review or fulfillment, your order becomes final and non-refundable.” In practice that means the refund window ends at intake approval, not at delivery.

Who it suits

A reasonable fit if you…

  • Want the option of an FDA-approved product rather than compounded only
  • Want to compare compounded and brand-name pricing on one page before deciding
  • Want precise dose strengths — unusually, their ED products publish them
  • Value unlimited provider messaging, which they include

Look elsewhere if you…

  • Want predictable monthly billing
  • Need to know which states are served before signing up
  • Want contraindications published before you buy
  • Want to know which pharmacy dispenses your medication

What WellMedr prescribes

Weight loss

CompoundedTirzepatide and semaglutide, injectable; oral formulations of both
Brand-nameOzempic® (semaglutide) and Zepbound® (tirzepatide)
Microdose lineSemaglutide with NAD+ and vitamin B12
PricingSee brand site

Men’s health

The Black PillSildenafil 110 mg + tadalafil 22 mg, or sildenafil 55 mg + tadalafil 11 mg
Multi-ingredient4-in-1 with sildenafil, tadalafil, vardenafil, apomorphine; 3-in-1 tri-blends
TestosteroneEnclomiphene 12.5 / 25 mg ODT with anastrozole
HairOral minoxidil with finasteride and biotin
PricingSee brand site
Credit where it is due on dose transparency. Publishing “sildenafil 110 mg + tadalafil 22 mg” is more than almost anyone else in this category does. Note that 110 mg of sildenafil sits above the 100 mg maximum in the FDA label for the single-molecule product, and it is combined with a second PDE5 inhibitor — a combination no FDA-approved product contains. That is a question for the prescribing clinician, not a reason to skip it, but it is a question. See our label comparison.

How ordering works

  1. Complete the three-minute assessment or the chat-based intake. No commitment at this stage.
  2. A licensed clinician reviews it and builds a treatment plan, or declines — WellMedr states providers “retain full discretion to prescribe or decline.”
  3. Orders ship in unbranded packaging, typically 1–2 business days after approval.
  4. Refills continue automatically on the renewal cycle, with unlimited provider messaging in between.

Their telehealth consent notes an at-home diagnostic test may be required in some cases, supplied by third-party laboratories. It is conditional rather than a standard part of the weight-loss programme.

State rules differ, and WellMedr does not publish a list. Their About page says services are “available in all 50 states”; the FAQ says they ship “to all U.S. states where our services are available”; the NAD+ page says “we currently serve most US states.” Those three statements do not agree. Their telehealth consent does carry specific carve-outs for Alaska, California, Connecticut, Kansas, New Hampshire, New Jersey, Ohio, South Carolina and Texas. Eligibility is checked during sign-up — confirm before paying.

What to know before you order

We could not find contraindication content for the GLP-1 products

Worth raising yourself. We looked for the standard GLP-1 warnings on WellMedr’s pages — the thyroid C-cell boxed warning, the MEN 2 contraindication, pregnancy, pancreatitis — across the home page, weight-loss pages, the get-started page, the FAQ, a product page, the terms and the telehealth consent. We did not find them. That does not mean the intake fails to screen for them; it means a prospective patient cannot see them before buying. The contraindications that apply are in who qualifies for GLP-1 treatment — read them, and make sure the intake asks.

Compounded and brand-name, side by side

WellMedr states: “Compounded medications offered through Wellmedr. are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.” That is the correct disclosure and it appears in several places.

One inconsistency: their FAQ also says they work only with pharmacies “that dispense FDA-approved medications”, which sits awkwardly next to their own compounded disclaimer. Both statements are on the site.

The genuine advantage here is choice. Most competitors decide for you by offering compounded only. See compounded vs brand-name.

No pharmacy is named

WellMedr refers to “FDA-registered facilities”, “certified U.S. pharmacies” and “accredited U.S. pharmacies”, but names none, and does not state 503A or 503B status.

Who should not use it

Not for everyone. GLP-1 medications are contraindicated in anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, and are not for use in pregnancy. Their ED products contain PDE5 inhibitors, which must never be combined with nitrates in any form, including recreational nitrites, or with guanylate cyclase stimulators such as riociguat. Enclomiphene is not FDA-approved for any indication. Anastrozole is an aromatase inhibitor with its own risk profile. Discuss all of it with a clinician who knows your history.

How we rated WellMedr

We do not test prescription services and we did not become a patient. This rating is based on our analysis of WellMedr’s own published pages read in August 2026 — product and pricing pages, FAQ, terms, telehealth consent and refund policy — plus the FDA prescribing information for the molecules involved, following our review methodology. It reflects transparency and clarity of terms, not treatment outcomes.

What lifted it: real brand-name options, published ED dose strengths, a named clinical partner, unlimited messaging. What held it down: a 21-day renewal presented as monthly, three mutually inconsistent statements about state coverage, no findable contraindication content, no named pharmacy, and a refund window that closes at intake approval.

Frequently asked questions

Is billing monthly?

No. Their refund and cancellation policy states the subscription renews every 21 days.

Can I get Ozempic or Zepbound?

Yes. WellMedr lists both brand-name products alongside compounded options, at a considerably higher tier.

Which states do they serve?

They do not publish a list, and their own pages give three different answers. Eligibility is checked at sign-up.

When can I still get a refund?

Before your intake is approved and sent to a provider or pharmacy. After that, their policy states the order is final.

Bottom line

WellMedr is one of the few services in this category that lets you choose an FDA-approved product instead of deciding for you, and its dose transparency on the men’s health side is better than the norm. The reservations are about clarity rather than capability: a billing interval most people will misread, a state policy that contradicts itself three ways, and safety information that is not where a buyer would look for it. If you go ahead, get your renewal interval and your state eligibility confirmed in writing first.

Looking at WellMedr?

Confirm your renewal interval and state eligibility before you pay.

Visit WellMedr

Medical disclaimer. This article is for general information only and is not medical advice. It is not intended to diagnose, treat, cure or prevent any condition. Prescription treatments require evaluation by a US-licensed clinician, who decides whether treatment is appropriate for you. Talk to your own healthcare provider before starting, stopping or changing any medication. Never combine a PDE5 inhibitor with any nitrate. Individual results vary.

Published August 2026 · Last reviewed August 2026 · Editorial policy · About BalanzGM

Balanzgm Editorial Team
Balanzgm Editorial Team

BalanzGM is an independent editorial publication that reviews direct-to-consumer health services and products sold to readers in the United States — telehealth weight-loss and men's health programs, and hemp-derived wellness products. We research each provider from material anyone can check for themselves: the provider's own published information and terms, FDA records and prescribing information, third-party lab documentation and certifications where they exist, and aggregated customer feedback from verified retailers and public review platforms. We do not conduct first-person product testing and we are not a clinical or scientific testing laboratory. Nothing we publish is medical advice. We disclose every affiliate relationship clearly and never accept paid placements.

BalanzGM
Logo